FMP
CorMedix Inc.
CRMD
NASDAQ
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
5.38 USD
-0.46 (-8.55%)
About
ceo
Mr. Joseph Todisco MBA
sector
Healthcare
industry
Biotechnology
website
https://www.cormedix.com
exchange
NASDAQ
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley ...
CIK
0001410098
ISIN
US21900C3088
CUSIP
21900C308
Address
300 Connell Drive
Phone
908 517 9500
Country
US
Employee
40
IPO Date
May 13, 2010
Summary
CIK
0001410098
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
21900C308
ISIN
US21900C3088
Country
US
Price
5.38
Beta
1.85
Volume Avg.
531.23k
Market Cap
294.89M
Shares
-
52-Week
2.57-7.0
DCF
1.05
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-6.33
P/B
-
Website
https://www.cormedix.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CRMD News
It looks like there's no news available.
